Cell therapy represents a treatment method involving the injection of active cells into a patient's body to address specific disorders, aiming to modify sets of cells for disease treatment. This technique involves modifying cells outside the body, derived either from the patient or a donor, and then reintroducing them into the patient's system.
The primary product categories encompass consumables, equipment, systems, and software. Consumables refer to items intended for depletion or use during regular application. They find application across various cell types such as T-cells, stem cells, and others. Processes within cell therapy technologies include cell processing, preservation, distribution, handling, process monitoring, and quality control. These technologies have diverse applications spanning life science companies, research institutes, and cell banks.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The cell therapy technologies market research report is one of a series of new reports from The Business Research Company that provides cell therapy technologies market statistics, including cell therapy technologies industry global market size, regional shares, competitors with a cell therapy technologies market share, detailed cell therapy technologies market segments, market trends, and opportunities, and any further data you may need to thrive in the cell therapy technologies industry. This cell therapy technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell therapy technologies market size has grown rapidly in recent years. It will grow from $4.92 billion in 2024 to $5.67 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increased healthcare expenditure, increased investments by the government in cell-based research, and growing demand for personalized medicine.
The cell therapy technologies market size is expected to see rapid growth in the next few years. It will grow to $9.87 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to rising aging population, increasing prevalence of cancer, increasing research and development spending in pharmaceutical sector, and advancements in cell therapies. Major trends in the forecast period include developing innovative products, using advanced technologies, development of innovative cell therapies, investing in manufacturing facilities, and partnerships and collaborations.
The forecast of 14.9% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of automated cell processing systems and bioreactors sourced from Germany and Switzerland, thereby delaying regenerative treatments and elevating cell therapy manufacturing costs by 25-40%. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The global cell therapy technologies market has experienced growth, driven by increasing government investments in cell-based research. Governments are allocating funds to support research activities focused on developing therapies for various diseases, including cancer, cardiovascular disease (CVD), and more. An example of this investment trend is observed in the actions of The California Institute for Regenerative Medicine (CIRM), a research center dedicated to stem cell research. In May 2022, CIRM invested over $11 million to fund a clinical trial for a cell therapy designed to treat throat cancer. The success of this therapy could potentially spare patients from undergoing radiotherapy and its associated side effects.
The rising incidence of cancer is anticipated to fuel the growth of the cell therapy technologies market throughout the forecast period. Cell therapy utilizes living cells as therapeutic agents to combat diseases. In the context of cancer treatment, cell therapy harnesses the immune system's natural capability to identify and eliminate abnormal cells within the body. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported that the number of cancer cases rose to 2,001,140, up from 1,958,310 in 2023, indicating a growth of 2.19%. Consequently, the increase in cancer cases is expected to significantly contribute to the expansion of the cell therapy technologies market in the future.
Major companies are focusing on developing innovative products using advanced technologies to achieve growth in the dynamic landscape of the cell therapy technologies market. An illustrative example of this trend is seen in the actions of Invetech, an Australia-based company specializing in the design, engineering, and manufacture of commercial-scale diagnostic products and cell and gene therapies. In June 2022, Invetech launched Korus, a novel closed system for autologous cell therapies. Korus is designed to redefine industry standards in elutriation and cell wash by utilizing a mild elutriation process that provides a cleaner cell population for various cell therapy production processes, such as tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cells, or induced pluripotent stem cell (IPSC)-derived therapy. The technology features elutriation and cell wash using gentle counterflow centrifugation, resulting in purified cell populations for downstream processing development and commercial manufacture. Korus aims to enhance overall process performance through improved recovery and purity of target cells, enabling developers to expedite clinical development and scale-up of their products.
Product innovation remains a key focus in the cell therapy technologies market, with companies striving to develop cutting-edge products to solidify their market positions. In September 2022, denovoMATRIX GmbH, a Germany-based innovator in cell and gene therapy manufacturing, launched animal component-free cell culture product lines at cell therapy grade (CTG). These product lines are equipped with documentation and traceability information to comply with industry regulatory standards, catering to the stem cell therapy manufacturing market. Additionally, in December 2021, Novartis, a Switzerland-based pharmaceutical corporation, introduced T-Charge, its next-generation CAR-T platform. T-Charge serves as the foundation for various new investigational CAR-T cell therapies in the Novartis pipeline. The platform preserves T cell stemness, enhancing proliferative potential and reducing exhausted T cells in the product. With T-Charge, CAR-T cell expansion primarily occurs within a patient's body (in-vivo), eliminating the need for extended culture time outside the body (ex-vivo). These unique characteristics contribute to better and more durable therapeutic responses, improved long-term outcomes, and a reduced risk of severe adverse events.
In July 2022, Evotec, a German biotechnology company, acquired Rigenerand Srl for an undisclosed sum. This acquisition integrates Rigenerand, a cutting-edge cell technology firm specializing in cGMP (current good manufacturing practice) production of cell therapies based in Medolla, Italy, which will now operate under the name Evotec (Modena) Srl. Rigenerand Srl originally hails from Italy and is focused on advanced cell technology.
Major companies operating in the cell therapy technologies market include Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline plc, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd, Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.
North America was the largest region in the cell therapy technologies market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell therapy technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The cell therapy market consists of sales of cell therapy technologies that are medicinal solutions used for developing and improving cell therapy, such as cell processing, cell banking, and point-of-care technologies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Therapy Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell therapy technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell therapy technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy technologies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Consumables, Equipment, Systems And Software
- 2) By Cell Type: T-Cells, Stem Cells, Other Cells
- 3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control
- 4) By End User: Life Science Companies, Research Institutes And Cell Banks
- Subsegments:
- 1) By Consumables: Cell Culture Media; Bioreactors And Cell Culture Vessels; Cell Separation And Processing Kits; Cryopreservation Bags And Vials
- 2) By Equipment: Cell Counters; Centrifuges; Cell Sorting Equipment; Incubators
- 3) By Systems And Software: Closed-System Cell Processing Systems; Automated Cell Culture Systems; Point-Of-Care Cell Therapy Systems; Laboratory Information Management Systems (LIMS); Data Management Software For Cell Therapies; Process Optimization And Tracking Software
- Companies Mentioned: Lonza Group AG; Thermo Fisher Scientific Inc; Merck KGaA; Terumo Corporation; Danaher Corporation; Fresenius Medical Care AG & Co. KGaA; Fujifilm Holdings Corporation; Sartorius AG; Becton Dickinson and Company; Avantor Inc.; Cellular Biomedicine Group; CORESTEM; Astellas Pharma Inc; Anterogen Co. Ltd; Arce Therapeutics; CARsgen Therapeutics; Huadong Medicine; Co.Don AG; AstraZeneca; Neogene Therapeutics; GammaDelta Therapeutics Limited; Nightstar; SOTIO; Accell Clinical Research; Genestack; Novartis AG; Pfizer; Celgene Corporation; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Bayer AG; Gilead Sciences; Juno Therapeutics; Allogene Therapeutics; Bluebird Bio; Amgen; Regen BioPharma; Bellicum; Amgen Brazil; GlaxoSmithKline plc; Biogen Brazil; Takeda Pharmaceutical Company Limited; Pfizer S.R.L; Biotchpharma; BrainStorm Cell Therapeutics; Pluristem; Bayer East Africa Ltd; Adcock Ingram; Next BioSciences; CryoSave; BioHeart; Stem Cell Technologies.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cell Therapy Technologies Market Characteristics
3. Cell Therapy Technologies Market Trends And Strategies
4. Cell Therapy Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cell Therapy Technologies Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cell Therapy Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cell Therapy Technologies Market Growth Rate Analysis
- 5.4. Global Cell Therapy Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cell Therapy Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cell Therapy Technologies Total Addressable Market (TAM)
6. Cell Therapy Technologies Market Segmentation
- 6.1. Global Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Consumables
- Equipment
- Systems And Software
- 6.2. Global Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- T-Cells
- Stem Cells
- Other Cells
- 6.3. Global Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Processing
- Cell Preservation
- Distribution And Handling
- Process Monitoring And Quality Control
- 6.4. Global Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Life Science Companies
- Research Institutes And Cell Banks
- 6.5. Global Cell Therapy Technologies Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Culture Media
- Bioreactors And Cell Culture Vessels
- Cell Separation And Processing Kits
- Cryopreservation Bags And Vials
- 6.6. Global Cell Therapy Technologies Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Counters
- Centrifuges
- Cell Sorting Equipment
- Incubators
- 6.7. Global Cell Therapy Technologies Market, Sub-Segmentation Of Systems And Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Closed-System Cell Processing Systems
- Automated Cell Culture Systems
- Point-Of-Care Cell Therapy Systems
- Laboratory Information Management Systems (LIMS)
- Data Management Software For Cell Therapies
- Process Optimization And Tracking Software
7. Cell Therapy Technologies Market Regional And Country Analysis
- 7.1. Global Cell Therapy Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cell Therapy Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cell Therapy Technologies Market
- 8.1. Asia-Pacific Cell Therapy Technologies Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cell Therapy Technologies Market
- 9.1. China Cell Therapy Technologies Market Overview
- 9.2. China Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cell Therapy Technologies Market
- 10.1. India Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cell Therapy Technologies Market
- 11.1. Japan Cell Therapy Technologies Market Overview
- 11.2. Japan Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cell Therapy Technologies Market
- 12.1. Australia Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cell Therapy Technologies Market
- 13.1. Indonesia Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cell Therapy Technologies Market
- 14.1. South Korea Cell Therapy Technologies Market Overview
- 14.2. South Korea Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cell Therapy Technologies Market
- 15.1. Western Europe Cell Therapy Technologies Market Overview
- 15.2. Western Europe Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cell Therapy Technologies Market
- 16.1. UK Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cell Therapy Technologies Market
- 17.1. Germany Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cell Therapy Technologies Market
- 18.1. France Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cell Therapy Technologies Market
- 19.1. Italy Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cell Therapy Technologies Market
- 20.1. Spain Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cell Therapy Technologies Market
- 21.1. Eastern Europe Cell Therapy Technologies Market Overview
- 21.2. Eastern Europe Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cell Therapy Technologies Market
- 22.1. Russia Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cell Therapy Technologies Market
- 23.1. North America Cell Therapy Technologies Market Overview
- 23.2. North America Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cell Therapy Technologies Market
- 24.1. USA Cell Therapy Technologies Market Overview
- 24.2. USA Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cell Therapy Technologies Market
- 25.1. Canada Cell Therapy Technologies Market Overview
- 25.2. Canada Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cell Therapy Technologies Market
- 26.1. South America Cell Therapy Technologies Market Overview
- 26.2. South America Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cell Therapy Technologies Market
- 27.1. Brazil Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cell Therapy Technologies Market
- 28.1. Middle East Cell Therapy Technologies Market Overview
- 28.2. Middle East Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cell Therapy Technologies Market
- 29.1. Africa Cell Therapy Technologies Market Overview
- 29.2. Africa Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cell Therapy Technologies Market Competitive Landscape And Company Profiles
- 30.1. Cell Therapy Technologies Market Competitive Landscape
- 30.2. Cell Therapy Technologies Market Company Profiles
- 30.2.1. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Cell Therapy Technologies Market Other Major And Innovative Companies
- 31.1. Fresenius Medical Care AG & Co. KGaA
- 31.2. Fujifilm Holdings Corporation
- 31.3. Sartorius AG
- 31.4. Becton Dickinson and Company
- 31.5. Avantor Inc.
- 31.6. Cellular Biomedicine Group
- 31.7. CORESTEM
- 31.8. Astellas Pharma Inc
- 31.9. Anterogen Co. Ltd
- 31.10. Arce Therapeutics
- 31.11. CARsgen Therapeutics
- 31.12. Huadong Medicine
- 31.13. Co.Don AG
- 31.14. AstraZeneca
- 31.15. Neogene Therapeutics
32. Global Cell Therapy Technologies Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cell Therapy Technologies Market
34. Recent Developments In The Cell Therapy Technologies Market
35. Cell Therapy Technologies Market High Potential Countries, Segments and Strategies
- 35.1 Cell Therapy Technologies Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cell Therapy Technologies Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cell Therapy Technologies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
